Key highlights
- BASF completed the sale of its optical brightening agent business to Catexel in February 2026.
- The transaction includes production at the Monthey site in Switzerland.
- Around 80 employees will transfer to Catexel as part of the deal.
Transaction Completion
The sale of BASF's optical brightening agent business to Catexel was finalized at the end of February 2026. The financial details of the transaction remain confidential.
Scope of the Deal
The transaction includes the international business and the production of optical brightening agents at the Monthey site in Switzerland. As part of the divestment, approximately 80 employees will transfer to Catexel.
About Catexel
Catexel, part of the International Chemical Investors Group (ICIG), specializes in high-quality specialty chemicals for detergents, cleaning products, personal care, and industrial applications.
